Evidence map›Paper›PMID 27492138›Full record

ArticleScientific reports2016

Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis.

Makoto Araki, Takeshi Matsubara, Hideharu Abe, Kazuo Torikoshi, Akira Mima, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Hidenori Arai, Toshio Doi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Makoto ArakiDepartment of Nephrology, Kyoto University, Kyoto, Japan.
Takeshi MatsubaraDepartment of Nephrology, Kyoto University, Kyoto, Japan.
Hideharu AbeDepartment of Nephrology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Kazuo TorikoshiDepartment of Nephrology, Kyoto University, Kyoto, Japan.
Akira MimaDepartment of Nephrology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Noriyuki IeharaDepartment of Nephrology, Kyoto University, Kyoto, Japan.
Atsushi FukatsuDepartment of Nephrology, Kyoto University, Kyoto, Japan.
Toru KitaKobe City Medical Center General Hospital, Kobe, Japan.
Hidenori AraiNational Center for Geriatrics and Gerontology, Obu, Japan.
Toshio DoiDepartment of Nephrology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Kyoto University · JPTokushima University · JPKobe City Medical Center General Hospital · JPNational Center for Geriatrics and Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix expansion and cell proliferation are concomitantly observed in various glomerular injuries. However, the molecular mechanisms responsible for these changes have not been fully elucidated. We have reported that Smad1 is a key signalling molecule that regulates the transcription of type IV collagen (Col4) in mesangial matrix expansion and is thereby involved in glomerular injury in an acute model of glomerulonephritis. In this study, we addressed the role of Smad1 signalling in accelerated nephrotoxic nephritis (NTN), a model of progressive glomerulonephritis, using conditional deletion of Smad1 in Rosa26CreERT2 mice (Smad1-CKO). Mesangial matrix expansion in the Smad1-CKO mice with NTN was significantly inhibited compared with that in wild type mice with NTN, which was consistent with the decrease in Col4 expression level. On the other hand, STAT3 activation and cell proliferation were not influenced by Smad1 deletion in the NTN model. Therefore, we investigated another factor that activates cell proliferation in the absence of Smad1. Id2 induced VEGF secretion and subsequent STAT3 activation, independently of Smad1 expression in mouse mesangial cells. Here we show that Smad1 plays an important role in the development of glomerular injury without affecting cell proliferation, in progressive glomerulonephritis.

Indexed as

Gene DeletionAnimalsCell ProliferationCollagen Type IVDisease Models, AnimalGlomerulonephritisInhibitor of Differentiation Protein 2MaleMiceSignal TransductionSmad1 ProteinSTAT3 Transcription FactorVascular Endothelial Growth Factor ACollagen Type IVIdb2 protein, mouseInhibitor of Differentiation Protein 2Smad1 ProteinSmad1 protein, mouseStat3 protein, mouseSTAT3 Transcription FactorVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID27492138
PMCPMC4974558
OpenAlexW2493808282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.